References
- DeMGhoshPRotelloVApplications of nanoparticles in biologyAdv Mater20082042254241
- FerrariMCancer nanotechnology: opportunities and challengesNat Rev Cancer20055316117115738981
- StephanMTMoonJJUmSHBershteynAIrvineDJTherapeutic cell engineering with surface-conjugated synthetic nanoparticlesNat Med20101691035104120711198
- ZhangLGuFXChanJMWangAZLangerRSFarokhzadOCNanoparticles in medicine: therapeutic applications and developmentsClin Pharmacol Ther200883576176917957183
- MauseSFWeberCMicroparticles: protagonists of a novel communication network for intercellular information exchangeCirc Res201010791047105721030722
- RakJMicroparticles in cancerSemin Thromb Hemost201036888890621049390
- GrefRMinamitakeYPeracchiaMTTrubetskoyVTorchilinVLangerRBiodegradable long-circulating polymeric nanospheresScience19942635153160016038128245
- GöppertTMMüllerRHPolysorbate-stabilized solid lipid nanoparticles as colloidal carriers for intravenous targeting of drugs to the brain: comparison of plasma protein adsorption patternsJ Drug Target200513317918716036306
- WalczykDBombelliFBMonopoliMPLynchIDawsonKAWhat the cell “sees” in bionanoscienceJ Am Chem Soc2010132165761576820356039
- YanYGauseKTKamphuisMMDifferential roles of the protein corona in the cellular uptake of nanoporous polymer particles by monocyte and macrophage cell linesACS Nano201323:712109601097024256422
- LeuDMantheyBKreuterJSpeiserPDeLucaPPDistribution and elimination of coated polymethyl [2–14C]methacrylate nanoparticles after intravenous injection in ratsJ Pharm Sci19847310143314376502493
- BalaIHariharanSKumarMNPLGA nanoparticles in drug delivery: the state of the artCrit Rev Ther Drug Carrier Syst200421538742215719481
- LesniakAFenaroliFMonopoliMPÅbergCDawsonKASalvatiAEffects of the presence or absence of a protein corona on silica nanoparticle uptake and impact on cellsACS Nano2012675845585722721453
- LesniakASalvatiASantos-MartinezMJRadomskiMWDawsonKAÅbergCNanoparticle adhesion to the cell membrane and its effect on nanoparticle uptake efficiencyJ Am Chem Soc201313541438144423301582
- TreuelLBrandholtSMaffrePWiegeleSShangLNienhausGUImpact of protein modification on the protein corona on nanoparticles and nanoparticle-cell interactionsACS Nano20148150351324377255
- HuWPengCLvMProtein corona-mediated mitigation of cytotoxicity of graphene oxideACS Nano2011553693370021500856
- YangSTLiuYWangYWCaoABiosafety and bioapplication of nanomaterials by designing protein-nanoparticle interactionsSmall201399–101635165323341247
- WalkeyCDChanWCUnderstanding and controlling the interaction of nanomaterials with proteins in a physiological environmentChem Soc Rev20124172780279922086677
- FenoglioIFubiniBGhibaudiEMTurciFMultiple aspects of the interaction of biomacromolecules with inorganic surfacesAdv Drug Deliv Rev201163131186120921871508
- MonopoliMPAbergCSalvatiADawsonKABiomolecular coronas provide the biological identity of nanosized materialsNat Nanotechnol201271277978623212421
- NelAEMädlerLVelegolDUnderstanding biophysicochemical interactions at the nano-bio interfaceNat Mater20098754355719525947
- WangXReeceSPBrownJMImmunotoxicological impact of engineered nanomaterial exposure: mechanisms of immune cell modulationToxicol Mech Methods201323316817723256453
- KarmaliPPSimbergDInteractions of nanoparticles with plasma proteins: implication on clearance and toxicity of drug delivery systemsExpert Opin Drug Deliv20118334335721291354
- CedervallTLynchILindmanSUnderstanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticlesProc Natl Acad Sci U S A200710472050205517267609
- MonopoliMPWalczykDCampbellAPhysical-chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticlesJ Am Chem Soc201113382525253421288025
- PeracchiaMTHarnischSPinto-AlphandaryHVisualization of in vitro protein-rejecting properties of PEGylated stealth polycyanoacrylate nanoparticlesBiomaterials199920141269127510403044
- GrefRLückMQuellecP‘Stealth’ corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorptionColloids Surf B Biointerfaces2000183–430131310915952
- GessnerAWaiczRLieskeAPaulkeBMäderKMüllerRHNanoparticles with decreasing surface hydrophobicities: influence on plasma protein adsorptionInt J Pharm2000196224524910699728
- GessnerALieskeAPaulkeBRMüllerRHFunctional groups on polystyrene model nanoparticles: influence on protein adsorptionJ Biomed Mater Res A200365331932612746878
- LacerdaSHParkJJMeuseCInteraction of gold nanoparticles with common human blood proteinsACS Nano20104136537920020753
- CasalsEPfallerTDuschlAOostinghGJPuntesVTime evolution of the nanoparticle protein coronaACS Nano2010473623363220553005
- MiclăuşTBochenkovVEOgakiRHowardKASutherlandDSSpatial mapping and quantification of soft and hard protein coronas at silver nanocubesNano Lett20141442086209324617413
- MedintzILKonnertJHClappARA fluorescence resonance energy transfer-derived structure of a quantum dot-protein bioconjugate nanoassemblyProc Natl Acad Sci U S A2004101269612961715210939
- Aubin-TamMEHamad-SchifferliKGold nanoparticle-cytochrome C complexes: the effect of nanoparticle ligand charge on protein structureLangmuir20052126120801208416342975
- RoachPFarrarDPerryCCSurface tailoring for controlled protein adsorption: effect of topography at the nanometer scale and chemistryJ Am Chem Soc2006128123939394516551101
- LundqvistMStiglerJEliaGLynchICedervallTDawsonKANanoparticle size and surface properties determine the protein corona with possible implications for biological impactsProc Natl Acad Sci U S A200810538142651427018809927
- TenzerSDocterDKuharevJRapid formation of plasma protein corona critically affects nanoparticle pathophysiologyNat Nanotechnol201381077278124056901
- De PaoliSHDiduchLLTegegnTZThe effect of protein corona composition on the interaction of carbon nanotubes with human blood plateletsBiomaterials201435246182619424831972
- HühnDKantnerKGeidelCPolymer-coated nanoparticles interacting with proteins and cells: focusing on the sign of the net chargeACS Nano2013743253326323566380
- LacerdaLBiancoAPratoMKostarelosKCarbon nanotubes as nanomedicines: from toxicology to pharmacologyAdv Drug Deliv Rev200658141460147017113677
- LiuZRobinsonJTTabakmanSMYangKDaiHCarbon materials for drug delivery and cancer therapyMater Today2011147–8316323
- CaiXRamalingamRWongHSCharacterization of carbon nanotube protein corona by using quantitative proteomicsNanomedicine (Lond)201395583593
- GeCDuJZhaoLBinding of blood proteins to carbon nanotubes reduces cytotoxicityProc Natl Acad Sci U S A201110841169681697321969544
- ZhuYLiWLiQEffects of serum proteins on intracellular uptake and cytotoxicity of carbon nanoparticlesCarbon200947513511358
- ParkSJKhangDConformational changes of fibrinogen in dispersed carbon nanotubesInt J Nanomedicine201274325433322915854
- MaoHYLaurentSChenWGraphene: promises, facts, opportunities, and challenges in nanomedicineChem Rev201311353407342423452512
- MaoHChenWLaurentSHard corona composition and cellular toxicities of the graphene sheetsColloids Surf B Biointerfaces201310921221823643918
- LemarchandCGrefRPassiraniCInfluence of polysaccharide coating on the interactions of nanoparticles with biological systemsBiomaterials200627110811816118015
- CasalsEPfallerTDuschlAOostinghGJPuntesVFHardening of the nanoparticle-protein corona in metal (Au, Ag) and oxide (Fe3O4, CoO, and CeO2) nanoparticlesSmall20117243479348622058075
- Braydich-StolleLHussainSSchlagerJJHofmannMCIn vitro cytotoxicity of nanoparticles in mammalian germline stem cellsToxicol Sci200588241241916014736
- AshaRaniPVLow Kah MunGHandeMPValiyaveettilSCytotoxicity and genotoxicity of silver nanoparticles in human cellsACS Nano20093227929019236062
- KittlerSGreulichCDiendorfJKöllerMEppleMToxicity of Silver Nanoparticles Increases during Storage Because of Slow Dissolution under Release of Silver IonsChem Mater2010221645484554
- MaioranoGSabellaSSorceBBrunettiVMalvindiMACingolaniRPompaPPEffects of cell culture media on the dynamic formation of protein-nanoparticle complexes and influence on the cellular responseACS Nano20104127481749121082814
- LynchISalvatiADawsonKAProtein-nanoparticle interactions: What does the cell see?Nat Nanotechnol20094954654719734922
- MüllerKHMotskinMPhilpottAJThe effect of particle agglomeration on the formation of a surface-connected compartment induced by hydroxyapatite nanoparticles in human monocyte-derived macrophagesBiomaterials20143531074108824183166
- MotskinMMüllerKHGenoudCMonteithAGSkepperJNThe sequestration of hydroxyapatite nanoparticles by human monocyte-macrophages in a compartment that allows free diffusion with the extracellular environmentBiomaterials201132359470948221889202
- SalmonJEKapurSKimberlyRPOpsonin-independent ligation of Fc gamma receptors. The 3G8-bearing receptors on neutrophils mediate the phagocytosis of concanavalin A-treated erythrocytes and nonopsonized Escherichia coliJ Exp Med19871666179818132445895
- HarashimaHSakataKFunatoKKiwadaHEnhanced hepatic uptake of liposomes through complement activation depending on the size of liposomesPharm Res19941134024068008707
- LerouxJCDe JaeghereFAnnerBDoelkerEGurnyRAn investigation on the role of plasma and serum opsonins on the internalization of biodegradable poly(D,L-lactic acid) nanoparticles by human monocytesLife Sci19955776957037637541
- SimRBTsiftsoglouSAProteases of the complement systemBiochem Soc Trans200432Pt 1212714748705
- Rybak-SmithMJSim RB; Rybak-SmithMJComplement activation by carbon nanotubesAdv Drug Deliv Rev201163121031104121669239
- BertholonIVauthierCLabarreDComplement activation by core-shell poly(isobutylcyanoacrylate)-polysaccharide nanoparticles: influences of surface morphology, length, and type of polysaccharidePharm Res20062361313132316715369
- HulanderMLundgrenABerglinMOhrlanderMLausmaaJElwingHImmune complement activation is attenuated by surface nanotopographyInt J Nanomedicine201162653266622114496
- GorbetMBSeftonMVBiomaterial-associated thrombosis: roles of coagulation factors, complement, platelets and leukocytesBiomaterials200425265681570315147815
- Salvador-MoralesCFlahautESimESloanJGreenMLSimRBSalvador-MoralesCComplement activation and protein adsorption by carbon nanotubesMol Immunol200643319320116199256
- KouserLAbdul-AzizMNayakAStoverCMSimRBKishoreUProperdin and factor h: opposing players on the alternative complement pathway “see-saw”Front Immunol201349323630525
- HorbettTChapter 13 Principles underlying the role of adsorbed plasma proteins in blood interactions with foreign materialsCardiovasc Pathol199323137148
- ChinnJAHorbettTARatnerBDBaboon fibrinogen adsorption and platelet adhesion to polymeric materialsThromb Haemost19916556086171871724
- LishkoVKPodolnikovaNPYakubenkoVPMultiple binding sites in fibrinogen for integrin alphaMbeta2 (Mac-1)J Biol Chem200422;279434489744906
- DingZMBabenseeJESimonSIRelative contribution of LFA-1 and Mac-1 to neutrophil adhesion and migrationJ Immunol199916395029503810528208
- DengZJLiangMMonteiroMTothIMinchinRFNanoparticle-induced unfolding of fibrinogen promotes Mac-1 receptor activation and inflammationNat Nanotechnol201161394421170037